Position in MTD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$717,012,379
-$92,324,617 QoQ
Shares Held
568,516
-2.1% QoQ
Ownership
2.81%
of shares outstanding
% of Portfolio
5.59%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MTD Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Fundsmith LLP holds $2,527,271,355 across 4 Diagnostics & Research names. MTD ranks #3 (28.4% of the industry book) .
All Filings in MTD
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $717,012,379 | 568,516 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $809,336,996 | 580,507 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $725,092,756 | 590,654 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $693,128,264 | 590,037 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $697,726,502 | 590,838 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $723,751,713 | 591,455 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $887,700,924 | 591,919 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $826,779,304 | 591,575 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $812,214,703 | 610,096 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $688,467,605 | 567,593 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $629,959,899 | 568,520 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $746,512,036 | 569,144 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $859,081,316 | 561,414 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $810,752,905 | 560,900 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $608,685,678 | 561,456 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $620,855,044 | 540,452 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $566,582,272 | 412,603 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||